Small, Nonpeptide p75NTR Ligands Induce Survival Signaling and Inhibit proNGF-Induced Death

Studies showing that neurotrophin binding to p75NTR can promote cell survival in the absence of Trk (tropomyosin-related kinase) receptors, together with recent structural data indicating that NGF may bind to p75NTR in a monovalent manner, raise the possibility that small molecule p75NTR ligands that positively regulate survival might be found. A pharmacophore designed to capture selected structural and physical chemical features of a neurotrophin domain known to interact with p75NTR was applied to in silico screening of small molecule libraries. Small, nonpeptide, monomeric compounds were identified that interact with p75NTR. In cells showing trophic responses to neurotrophins, the compounds promoted survival signaling through p75NTR-dependent mechanisms. In cells susceptible to proneurotrophin-induced death, compounds did not induce apoptosis but inhibited proneurotrophin-mediated death. These studies identify a unique range of p75NTR behaviors that can result from isolated receptor liganding and establish several novel therapeutic leads.

[1]  E. Wheeler,et al.  p75NTR‐mediated signaling promotes the survival of myoblasts and influences muscle strength , 2005, Journal of cellular physiology.

[2]  Yoshua Bengio,et al.  Selective small molecule peptidomimetic ligands of TrkC and TrkA receptors afford discrete or complete neurotrophic activities. , 2005, Chemistry & biology.

[3]  Petti T. Pang,et al.  The yin and yang of neurotrophin action , 2005, Nature Reviews Neuroscience.

[4]  Youmei Xie,et al.  Neurotrophin Small Molecule Mimetics: Candidate Therapeutic Agents for Neurological Disorders , 2005 .

[5]  T. Willnow,et al.  p75NTR – live or let die , 2005, Current Opinion in Neurobiology.

[6]  I. Kostova Synthetic and natural coumarins as cytotoxic agents. , 2005, Current medicinal chemistry. Anti-cancer agents.

[7]  Osman Güner,et al.  Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances. , 2004, Current medicinal chemistry.

[8]  A. Christopoulos,et al.  Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting , 2004 .

[9]  K. Garcia,et al.  Structure of Nerve Growth Factor Complexed with the Shared Neurotrophin Receptor p75 , 2004, Science.

[10]  M. Meyer,et al.  Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Barbara L. Hempstead,et al.  Sortilin is essential for proNGF-induced neuronal cell death , 2004, Nature.

[12]  V. Mamidipudi,et al.  Regulation of Interleukin Receptor-associated Kinase (IRAK) Phosphorylation and Signaling by Iota Protein Kinase C* , 2004, Journal of Biological Chemistry.

[13]  Arthur Christopoulos,et al.  International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology , 2003, Pharmacological Reviews.

[14]  E. Huang,et al.  Trk receptors: roles in neuronal signal transduction. , 2003, Annual review of biochemistry.

[15]  T. Berg Modulation of protein-protein interactions with small organic molecules. , 2003, Angewandte Chemie.

[16]  R. Bernabeu,et al.  Leukocyte Antigen-Related Protein Tyrosine Phosphatase Receptor: A Small Ectodomain Isoform Functions as a Homophilic Ligand and Promotes Neurite Outgrowth , 2003, The Journal of Neuroscience.

[17]  M. Chao,et al.  Neurotrophins and their receptors: A convergence point for many signalling pathways , 2003, Nature Reviews Neuroscience.

[18]  P. J. Condon,et al.  Novel functional interactions between Trk kinase and p75 neurotrophin receptor in neuroblastoma cells , 2003, Journal of neuroscience research.

[19]  K. Teng,et al.  Neurotrophins and their receptors: signaling trios in complex biological systems , 2003, Cellular and Molecular Life Sciences CMLS.

[20]  Osman F Güner,et al.  History and evolution of the pharmacophore concept in computer-aided drug design. , 2002, Current topics in medicinal chemistry.

[21]  J. Kim,et al.  ProNGF Induces p75-Mediated Death of Oligodendrocytes following Spinal Cord Injury , 2002, Neuron.

[22]  V. Mamidipudi,et al.  Identification of Interleukin 1 Receptor-associated Kinase as a Conserved Component in the p75-Neurotrophin Receptor Activation of Nuclear Factor-κB* , 2002, The Journal of Biological Chemistry.

[23]  Herman W. T. van Vlijmen,et al.  Identification of Potent and Novel α4β1 Antagonists Using in Silico Screening , 2002 .

[24]  D. Boger,et al.  Erythropoietin mimetics derived from solution phase combinatorial libraries. , 2002, Journal of the American Chemical Society.

[25]  J. Kim,et al.  Activation of Rac GTPase by p75 Is Necessary for c-jun N-Terminal Kinase-Mediated Apoptosis , 2002, The Journal of Neuroscience.

[26]  Identification of potent and novel alpha4beta1 antagonists using in silico screening. , 2002, Journal of medicinal chemistry.

[27]  Youmei Xie,et al.  Alzheimer's therapeutics: neurotrophin small molecule mimetics. , 2002, Journal of molecular neuroscience : MN.

[28]  Barbara L. Hempstead,et al.  Regulation of Cell Survival by Secreted Proneurotrophins , 2001, Science.

[29]  I. Enyedy,et al.  Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. , 2001, Journal of medicinal chemistry.

[30]  B. Michalski,et al.  The Precursor Pro-Nerve Growth Factor Is the Predominant Form of Nerve Growth Factor in Brain and Is Increased in Alzheimer's Disease , 2001, Molecular and Cellular Neuroscience.

[31]  C. Shatz,et al.  A Novel P75ntr Signaling Pathway Promotes Survival, Not Death, of Immunopurified Neocortical Subplate Neurons , 2022 .

[32]  W. Liang,et al.  Predicting blood-brain barrier penetration of drugs by polar molecular surface area and molecular volume. , 2001, Acta pharmacologica Sinica.

[33]  Y. Kurogi,et al.  Pharmacophore modeling and three-dimensional database searching for drug design using catalyst. , 2001, Current medicinal chemistry.

[34]  Philippe P Roux,et al.  The p75 Neurotrophin Receptor Activates Akt (Protein Kinase B) through a Phosphatidylinositol 3-Kinase-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[35]  A. Good,et al.  3-D pharmacophores in drug discovery. , 2001, Current pharmaceutical design.

[36]  P. Barker,et al.  The Atypical Protein Kinase C-interacting Protein p62 Is a Scaffold for NF-κB Activation by Nerve Growth Factor* , 2001, The Journal of Biological Chemistry.

[37]  W C Greene,et al.  NF-κB Signaling Promotes Both Cell Survival and Neurite Process Formation in Nerve Growth Factor-Stimulated PC12 Cells , 2000, The Journal of Neuroscience.

[38]  M. Peck,et al.  A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3 , 2000, The Journal of Biological Chemistry.

[39]  Philippe P Roux,et al.  NRAGE, A Novel MAGE Protein, Interacts with the p75 Neurotrophin Receptor and Facilitates Nerve Growth Factor–Dependent Apoptosis , 2000, Neuron.

[40]  G. Erkel Trichodion, a new inhibitor of inflammatory signal transduction pathways from a Trichosporiella species , 2000, FEBS letters.

[41]  C. Lipinski Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[42]  S. Srinivasula,et al.  Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  N. Assa‐Munt,et al.  Dimerization‐dependent block of the proapoptotic effect of P75NTR , 2000, Journal of neuroscience research.

[44]  K. Gehring,et al.  Genuine Monovalent Ligands of TrkA Nerve Growth Factor Receptors Reveal a Novel Pharmacological Mechanism of Action* , 2000, The Journal of Biological Chemistry.

[45]  P. Casaccia‐Bonnefil,et al.  Nerve Growth Factor Activation of Nuclear Factor κB through Its p75 Receptor Is an Anti-apoptotic Signal in RN22 Schwannoma Cells* , 2000, The Journal of Biological Chemistry.

[46]  A. Cuello,et al.  A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors. , 2000, Molecular pharmacology.

[47]  T. Kenakin,et al.  Quantitative Molecular Pharmacology and Informatics in Drug Discovery , 2000 .

[48]  S. DeArmond,et al.  Nerve Growth Factor Signaling in Caveolae-like Domains at the Plasma Membrane* , 1999, The Journal of Biological Chemistry.

[49]  H. Sakurai,et al.  IκB Kinases Phosphorylate NF-κB p65 Subunit on Serine 536 in the Transactivation Domain* , 1999, The Journal of Biological Chemistry.

[50]  A. Futerman,et al.  Ceramide Signaling Downstream of the p75 Neurotrophin Receptor Mediates the Effects of Nerve Growth Factor on Outgrowth of Cultured Hippocampal Neurons , 1999, The Journal of Neuroscience.

[51]  D. E. Clark,et al.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.

[52]  D. E. Clark Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.

[53]  J. Finke,et al.  Inhibition of NF-κB Activity in Human T Lymphocytes Induces Caspase-Dependent Apoptosis Without Detectable Activation of Caspase-1 and -3 , 1999, The Journal of Immunology.

[54]  R G Smith,et al.  Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. , 1999, Science.

[55]  F. Longo,et al.  Electromagnetic fields influence NGF activity and levels following sciatic nerve transection , 1999, Journal of neuroscience research.

[56]  M. Kawaja,et al.  Absence of the p75 Neurotrophin Receptor Alters the Pattern of Sympathosensory Sprouting in the Trigeminal Ganglia of Mice Overexpressing Nerve Growth Factor , 1999, The Journal of Neuroscience.

[57]  H. Sakurai,et al.  IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. , 1999, The Journal of biological chemistry.

[58]  J. Finke,et al.  Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. , 1999, Journal of immunology.

[59]  M. Koltzenburg,et al.  Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75 , 1998, Neuroscience Letters.

[60]  J G Gleason,et al.  A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns]. , 1998, Science.

[61]  Y Ikeda,et al.  A non‐peptide compound which can mimic the effect of thrombopoietin via c‐Mpl , 1998, FEBS letters.

[62]  M. Chao,et al.  Competitive Signaling Between TrkA and p75 Nerve Growth Factor Receptors Determines Cell Survival , 1998, The Journal of Neuroscience.

[63]  M. Manthorpe,et al.  Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor‐dependent mechanism , 1997, Journal of neuroscience research.

[64]  T. Satoh,et al.  A computer screening approach to immunoglobulin superfamily structures and interactions: discovery of small non-peptidic CD4 inhibitors as novel immunotherapeutics. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[65]  R. Dobrowsky,et al.  Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75 , 1996, Nature.

[66]  H. Thoenen,et al.  Autocrine—paracrine Regulation of Hippocampal Neuron Survival by IGF‐1 and the Neurotrophins BDNF, NT‐3 and NT‐4 , 1996, The European journal of neuroscience.

[67]  Y. Barde,et al.  Selective Activation of NF-κB by Nerve Growth Factor Through the Neurotrophin Receptor p75 , 1996, Science.

[68]  Y. Barde,et al.  Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. , 1996, Science.

[69]  C. Howe,et al.  A signaling endosome hypothesis to explain NGF actions: potential implications for neurodegeneration. , 1996, Cold Spring Harbor symposia on quantitative biology.

[70]  W. Mobley,et al.  Multiple Levels for Regulation of TrkA in PC12 Cells by Nerve Growth Factor , 1995, Journal of neurochemistry.

[71]  T. Torgerson,et al.  Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*) , 1995, The Journal of Biological Chemistry.

[72]  M. Chao,et al.  Mesenchymal and neuronal cell expression of the p75 neurotrophin receptor gene occur by different mechanisms. , 1995, Developmental biology.

[73]  P P Humphrey,et al.  International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. , 1994, Pharmacological reviews.

[74]  M. Barbacid,et al.  Signal transduction events mediated by the BDNF receptor gp 145trkB in primary hippocampal pyramidal cell culture , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[75]  Y. Li,et al.  Cultured hippocampal neurons show responses to BDNF, NT-3, and NT-4, but not NGF , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[76]  R. Jaenisch,et al.  Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system , 1992, Cell.

[77]  W. Mobley,et al.  The in vitro biological effect of nerve growth factor is inhibited by synthetic peptides. , 1990, Cell regulation.

[78]  I. Pastan,et al.  Direct visualization of binding, aggregation, and internalization of insulin and epidermal growth factor on living fibroblastic cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.